Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 814

1.

miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement.

Hoss AG, Labadorf A, Latourelle JC, Kartha VK, Hadzi TC, Gusella JF, MacDonald ME, Chen JF, Akbarian S, Weng Z, Vonsattel JP, Myers RH.

BMC Med Genomics. 2015 Mar 1;8:10. doi: 10.1186/s12920-015-0083-3.

2.

MicroRNAs located in the Hox gene clusters are implicated in huntington's disease pathogenesis.

Hoss AG, Kartha VK, Dong X, Latourelle JC, Dumitriu A, Hadzi TC, Macdonald ME, Gusella JF, Akbarian S, Chen JF, Weng Z, Myers RH.

PLoS Genet. 2014 Feb 27;10(2):e1004188. doi: 10.1371/journal.pgen.1004188. eCollection 2014 Feb.

3.

In silico analysis of regulatory networks underlines the role of miR-10b-5p and its target BDNF in huntington's disease.

Müller S.

Transl Neurodegener. 2014 Aug 18;3:17. doi: 10.1186/2047-9158-3-17. eCollection 2014.

4.

Circulating microRNAs in Huntington's disease: Emerging mediators in metabolic impairment.

Díez-Planelles C, Sánchez-Lozano P, Crespo MC, Gil-Zamorano J, Ribacoba R, González N, Suárez E, Martínez-Descals A, Martínez-Camblor P, Álvarez V, Martín-Hernández R, Huerta-Ruíz I, González-García I, Cosgaya JM, Visioli F, Dávalos A, Iglesias-Gutiérrez E, Tomás-Zapico C.

Pharmacol Res. 2016 Jun;108:102-110. doi: 10.1016/j.phrs.2016.05.005. Epub 2016 May 4.

PMID:
27155059
5.

Down-regulation of miR-9* in the peripheral leukocytes of Huntington's disease patients.

Chang KH, Wu YR, Chen CM.

Orphanet J Rare Dis. 2017 Dec 19;12(1):185. doi: 10.1186/s13023-017-0742-x.

6.

Interrogation of brain miRNA and mRNA expression profiles reveals a molecular regulatory network that is perturbed by mutant huntingtin.

Jin J, Cheng Y, Zhang Y, Wood W, Peng Q, Hutchison E, Mattson MP, Becker KG, Duan W.

J Neurochem. 2012 Nov;123(4):477-90. doi: 10.1111/j.1471-4159.2012.07925.x. Epub 2012 Sep 28.

7.

Altered microRNA regulation in Huntington's disease models.

Lee ST, Chu K, Im WS, Yoon HJ, Im JY, Park JE, Park KH, Jung KH, Lee SK, Kim M, Roh JK.

Exp Neurol. 2011 Jan;227(1):172-9. doi: 10.1016/j.expneurol.2010.10.012. Epub 2010 Oct 28.

PMID:
21035445
8.

Study of plasma-derived miRNAs mimic differences in Huntington's disease brain.

Hoss AG, Lagomarsino VN, Frank S, Hadzi TC, Myers RH, Latourelle JC.

Mov Disord. 2015 Dec;30(14):1961-4. doi: 10.1002/mds.26457. Epub 2015 Nov 17.

9.

Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.

Jin X, Chen Y, Chen H, Fei S, Chen D, Cai X, Liu L, Lin B, Su H, Zhao L, Su M, Pan H, Shen L, Xie D, Xie C.

Clin Cancer Res. 2017 Sep 1;23(17):5311-5319. doi: 10.1158/1078-0432.CCR-17-0577. Epub 2017 Jun 12.

10.

Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker.

Vilming Elgaaen B, Olstad OK, Haug KB, Brusletto B, Sandvik L, Staff AC, Gautvik KM, Davidson B.

BMC Cancer. 2014 Feb 11;14:80. doi: 10.1186/1471-2407-14-80.

11.

SOX11 identified by target gene evaluation of miRNAs differentially expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients.

Haenisch S, Zhao Y, Chhibber A, Kaiboriboon K, Do LV, Vogelgesang S, Barbaro NM, Alldredge BK, Lowenstein DH, Cascorbi I, Kroetz DL.

Neurobiol Dis. 2015 May;77:127-40. doi: 10.1016/j.nbd.2015.02.025. Epub 2015 Mar 10.

12.

Assessment of cortical and striatal involvement in 523 Huntington disease brains.

Hadzi TC, Hendricks AE, Latourelle JC, Lunetta KL, Cupples LA, Gillis T, Mysore JS, Gusella JF, MacDonald ME, Myers RH, Vonsattel JP.

Neurology. 2012 Oct 16;79(16):1708-15. doi: 10.1212/WNL.0b013e31826e9a5d. Epub 2012 Oct 3.

13.

Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing.

Agrawal R, Pandey P, Jha P, Dwivedi V, Sarkar C, Kulshreshtha R.

BMC Genomics. 2014 Aug 17;15:686. doi: 10.1186/1471-2164-15-686.

14.

Identification of a set of miRNAs differentially expressed in transiently TIA-depleted HeLa cells by genome-wide profiling.

Sánchez-Jiménez C, Carrascoso I, Barrero J, Izquierdo JM.

BMC Mol Biol. 2013 Feb 6;14:4. doi: 10.1186/1471-2199-14-4.

15.

Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis.

Braza-Boïls A, Salloum-Asfar S, Marí-Alexandre J, Arroyo AB, González-Conejero R, Barceló-Molina M, García-Oms J, Vicente V, Estellés A, Gilabert-Estellés J, Martínez C.

Hum Reprod. 2015 Oct;30(10):2292-302. doi: 10.1093/humrep/dev204. Epub 2015 Aug 25.

PMID:
26307093
16.

Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers.

Lugli G, Cohen AM, Bennett DA, Shah RC, Fields CJ, Hernandez AG, Smalheiser NR.

PLoS One. 2015 Oct 1;10(10):e0139233. doi: 10.1371/journal.pone.0139233. eCollection 2015.

17.
18.

Small RNA expression from viruses, bacteria and human miRNAs in colon cancer tissue and its association with microsatellite instability and tumor location.

Mjelle R, Sjursen W, Thommesen L, Sætrom P, Hofsli E.

BMC Cancer. 2019 Feb 20;19(1):161. doi: 10.1186/s12885-019-5330-0.

19.

Regulation of the MIR155 host gene in physiological and pathological processes.

Elton TS, Selemon H, Elton SM, Parinandi NL.

Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Review.

PMID:
23246696
20.

Differential expression of basal microRNAs' patterns in human dental pulp stem cells.

Vasanthan P, Govindasamy V, Gnanasegaran N, Kunasekaran W, Musa S, Abu Kasim NH.

J Cell Mol Med. 2015 Mar;19(3):566-80. doi: 10.1111/jcmm.12381. Epub 2014 Dec 5.

Supplemental Content

Support Center